Insight on Pharmaceuticals and Healthcare in Europe

Published within

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

Type Product title / description Pub Price
Report
Report

R&D Trends: Rheumatoid Arthritis – Approaching an era of novel kinase inhibitors

Review of candidates in development for rheumatoid arthritis across the seven major markets, highlighting key trends, as well as analyses of clinical trial design, innovative early-stage projects and hypothesizing on how future treatment may evolve.

Published By Datamonitor
01 Jul 2011 $2800
Buy
Report
Report

R&D Trends: Renal Cell Cancer – Crowded RCC market remains attractive to drug developers

Review of key R&D trends in renal cell cancer including; dynamics of the pipeline, comparator therapies, target product profile, trends in clinical trial design, innovative early-stage projects, and the future of colorectal cancer treatment.

Published By Datamonitor
09 Aug 2012 $2800
Buy

Order this report by 20th May 2011 and receive a 15% discount

To take advantage of this offer enter Promo Code CMDN17 when prompted in the checkout

More information

Report
Report

R&D Trends: Psoriasis - Pipeline outlook following withdrawal of key regulatory filing

Review of candidates in development for psoriasis across the seven major markets, highlighting key trends, as well as detailed analyses of clinical trial design, innovative early-stage projects and hypothesizing on how future treatment may evolve

Published By Datamonitor
16 Mar 2011 $2800
Buy
Report
Report

R&D Trends: Prostate Cancer - Newly approved therapies shift treatment dynamics for castrate-resistant disease

Review of key R&D trends in prostate cancer including; dynamics of the pipeline, comparator therapies, target product profile, trends in clinical trial design, innovative early-stage projects, and the future of prostate cancer treatment.

Published By Datamonitor
17 Jun 2011 $2800
Buy
Report
Report

R&D Trends: Parkinson's Disease – Pipeline swells but a paradigm shift is unlikely in the mid-term

Review of key trends in the development of new Parkinson’s disease drugs across the seven major markets. Includes detailed analyses of the composition of the pipeline, clinical trial design, target product profile, and future treatment developments.

Published By Datamonitor
15 Jun 2012 $2800
Buy
Report
Report

R&D Trends: Osteoporosis - Strong pipeline bodes well for future treatment

Review of key trends in the development of new osteoporosis drugs across the seven major markets. Also includes detailed analyses of clinical trial design, target product profile, innovative early-stage projects, and future treatment developments

Published By Datamonitor
01 Nov 2011 $2800
Buy
Report
Report

R&D Trends: Obesity - 2006–2011: obesity’s lean years

Datamonitor module assesses the current state of the obesity pipeline and trends that will shape its future. Focused on the US, Japan, France, Germany, Italy, Spain, and the UK

Published By Datamonitor
11 May 2011 $2800
Buy
Report
Report

R&D Trends: Non-Small Cell Lung Cancer - Mutation analyses continue driving treatment choices

Review of key R&D trends in non-small cell lung cancer (NSCLC) including; dynamics of the pipeline, comparator therapies, target product profile, trends in clinical trial design, innovative early-stage projects, and the future of NSCLC treatment.

Published By Datamonitor
10 Apr 2012 $2800
Buy
Report
Report

R&D Trends: Non-Insulin Antidiabetics - What opportunities remain for the vast pipeline in the crowded diabetes market?

Datamonitor module assesses the current state of the non-insulin antidiabetics pipeline and trends in clinical trial design and treatment that will shape its future. Focused on the US, Japan, France, Germany, Italy, Spain, and the UK

Published By Datamonitor
08 Jul 2011 $2800
Buy
Report
Report

R&D Trends: Neuropathic Pain - Extensive and diverse pipeline driven by high unmet need

This report reviews the key trends in the drug development pipeline for neuropathic pain. It also includes detailed analysis of clinical trial design, target product profile, innovative early-stage projects, and future treatments.

Published By Datamonitor
13 Jul 2011 $2800
Buy

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

No help is available.